Skip to search formSkip to main contentSkip to account menu

Atracurium

Known as: Atracurium [Chemical/Ingredient], Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl- 
A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
PurposeTo describe the prolonged effect of the intermediate-acting, non-depolarising neuromuscular blocking agents rocuronium and… 
Highly Cited
1988
Highly Cited
1988
Sixty patients (17–78 years old, ASA group I–II) were included in the study, which was triple–blind, randomised, stratified and… 
1987
1987
The advent of newer muscle relaxants with predictable rates of metabolism and times of offset of neuromuscular blockade now makes… 
Highly Cited
1987
Highly Cited
1987
We compared the incidence of postoperative myalgia (POM) and fasciculations when atracurium (ATR) or d-tubocurarine (DTC) was… 
1986
1986
Conditions excellentes d'intubation apres l'injection bolus de 1,5 mg/kg d'atracurium ou 0,25 mg/kg de vecuronium 
1985
1985
Pancuronium decreases the minimal alveolar anesthetic concentration (MAC) of halothane in humans, while atracurium has a… 
Highly Cited
1983
Highly Cited
1983
: A complete pharmacokinetic and pharmacodynamic model for the novel non-depolarizing neuromuscular blocking agent atracurium is… 
Review
1983
Review
1983
The search for new muscle relaxants is an attempt to improve on the undesirable pharmacologic properties of currently available… 
Highly Cited
1982
Highly Cited
1982
The neuromuscular effects of atracurium were studied in 25 A. S. A. class I or II patients anesthetized by a N2O-O2narcotic…